@article{bouchard_considerations_2004,

title = {Considerations in the use of exposure with children},

author = {S. Bouchard and S. L. Mendlowitz and M. E. Coles and M. Franklin},

url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-4143050390&doi=10.1016%2fS1077-7229%2804%2980007-5&partnerID=40&md5=e690830636b52fb317013801b5fc9159},

doi = {10.1016/S1077-7229(04)80007-5},

issn = {10777229 (ISSN)},

year  = {2004},

date = {2004-01-01},

journal = {Cognitive and Behavioral Practice},

volume = {11},

number = {1},

pages = {56–65+129},

abstract = {Exposure interventions, both imaginal and in vivo, are an integral part of cognitive behavioral treatments for anxiety disorders and have been found to be efficacious when used to treat various fears and phobias. Although most of the literature has focused on the use of exposure with adults, there is increasing interest in the use of these techniques with anxious children and adolescents. The premise underlying exposure's efficacy is that although it is initially uncomfortable, anxiety will eventually diminish and erroneous cognitions will be disconfirmed when one is exposed repeatedly to a feared stimulus in the absence of the feared negative consequence. In this article the use of exposure techniques with children and adolescents will be discussed, focusing particularly on increasing the developmental sensitivity of these techniques to maximize their effects for younger patients. Various exposure techniques in younger patients will be described, core principles of exposure treatment for anxious children will be delineated, and application for specific pediatric anxiety disorders will be discussed.},

note = {Publisher: Elsevier Inc.},

keywords = {Anxiety disorder, Child, child behavior, cognition, drug efficacy, exposure, Fear, human, phobia, priority journal, review, stimulus response},

pubstate = {published},

tppubtype = {article}

}

@article{savard_combination_1998,

title = {Combination of fluoxetine and cognitive therapy for the treatment of major depression among people with HIV infection: A time-series analysis investigation},

author = {J. Savard and B. Laberge and J. G. Gauthier and J. -P. Founder and S. Bouchard and J. -G. Baril and M. G. Bergeron},

url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031957952&doi=10.1023%2fA%3a1018759802082&partnerID=40&md5=bf7c480d95e52b00202cfcb1f34af74f},

doi = {10.1023/A:1018759802082},

issn = {01475916 (ISSN)},

year  = {1998},

date = {1998-01-01},

journal = {Cognitive Therapy and Research},

volume = {22},

number = {1},

pages = {21–46},

abstract = {The aim of the present study was to evaluate the efficacy of a combined treatment of fluoxetine and cognitive therapy for the treatment of major depression in HIV-infected patients. Six HIV-seropositive patients with major depression participated in this study using a multiple-baseline experimental design with follow-up and direct replications. Results of time-series intervention analyses suggest that the combination of fluoxetine and cognitive therapy can provide an effective treatment for major depression in HIV illness that may be more effective than fluoxetine alone. However, relapse rates and follow-up results raise some concerns about the long-term efficacy of the combined treatment as administered in this study. Cooccurence of a personality disorder is suggested as an explanatory hypothesis.},

note = {Publisher: Springer New York LLC},

keywords = {adult, AIDS, alcoholism, article, clinical article, clinical trial, clonazepam, cognitive therapy, comorbidity, demography, Depression, disease association, drug efficacy, female, fluoxetine, HIV, human, Human immunodeficiency virus infection, male, patient attitude, personality disorder, relapse, Treatment, treatment outcome},

pubstate = {published},

tppubtype = {article}

}